This post was originally published on this site
Agilent is a stock that gives exposure to the healthcare and pharmaceutical industry without the drawbacks and risks associated with drug development. The company is also a leading supplier of next-generation healthcare innovations like genomics and DNA sequencing.
In addition to the company’s crucial position in the supply chain of several industries, Agilent also benefits from positive, macro conditions that increase confidence, the company will deliver years of strong earnings and revenue growth.
